Fig. 5From: Antibody responses to a suite of novel serological markers for malaria surveillance demonstrate strong correlation with clinical and parasitological infection across seasons and transmission settings in The GambiaOdds of clinical malaria by compound sero-prevalence (a) and odds of asymptomatic infection by compound sero-prevalence (b). Analyses is adjusted for age group (< 5 years, 5–15 years, and > 15 years) and LLIN use in the last 24 h and weighted by compound sizeBack to article page